Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Aerts

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
Neuro-Oncology|June 13, 2017
Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastomaMark W Kieran, Julia Chisholm, Michela Casanova, et al.
JHEP Reports : Innovation in Hepatology|April 22, 2026
Molecular evolution of mosaic chromosome 18 copy-number alterations from gametes to hepatoblastomaElise Cendres, Marianna Cornet, Zoé Gautier, et al.
European Radiology|December 1, 2014
Assessment of early-stage optic nerve invasion in retinoblastoma using high-resolution 1.5 Tesla MRI with surface coils: a multicentre, prospective accuracy study with histopathological correlationHervé J Brisse, Pim de Graaf, Paolo Galluzzi, et al.
Neuro-Oncology|October 27, 2010
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumorsBirgit Geoerger, Darren Hargrave, Fabienne Thomas, et al.
JACC. Cardiooncology|January 11, 2024
Increased Cardiac Risk After a Second Malignant Neoplasm Among Childhood Cancer Survivors: A FCCSS StudyThibaud Charrier, Nadia Haddy, Boris Schwartz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2013
Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: a European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma studyAngela Di Giannatale, Nathalie Dias-Gastellier, Annick Devos, et al.
Pediatric Blood & Cancer|October 10, 2019
Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC studyGwénaël Le Teuff, Alicia Castaneda-Heredia, Christelle Dufour, et al.
The New England Journal of Medicine|September 21, 2023
Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 MutationsEric Bouffet, Jordan R Hansford, Maria Luisa Garrè, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2013
Second cranio-facial malignancies in hereditary retinoblastoma survivors previously treated with radiation therapy: clinic and radiologic characteristics and survival outcomesFirazia Rodjan, Pim de Graaf, Hervé J Brisse, et al.
Pediatric Blood & Cancer|November 30, 2016
Feasibility and clinical integration of molecular profiling for target identification in pediatric solid tumorsThomas Pincez, Nathalie Clément, Eve Lapouble, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Neuro-Oncology|June 13, 2017
Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastomaMark W Kieran, Julia Chisholm, Michela Casanova, et al.
JHEP Reports : Innovation in Hepatology|April 22, 2026
Molecular evolution of mosaic chromosome 18 copy-number alterations from gametes to hepatoblastomaElise Cendres, Marianna Cornet, Zoé Gautier, et al.
European Radiology|December 1, 2014
Assessment of early-stage optic nerve invasion in retinoblastoma using high-resolution 1.5 Tesla MRI with surface coils: a multicentre, prospective accuracy study with histopathological correlationHervé J Brisse, Pim de Graaf, Paolo Galluzzi, et al.
Neuro-Oncology|October 27, 2010
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumorsBirgit Geoerger, Darren Hargrave, Fabienne Thomas, et al.
JACC. Cardiooncology|January 11, 2024
Increased Cardiac Risk After a Second Malignant Neoplasm Among Childhood Cancer Survivors: A FCCSS StudyThibaud Charrier, Nadia Haddy, Boris Schwartz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2013
Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: a European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma studyAngela Di Giannatale, Nathalie Dias-Gastellier, Annick Devos, et al.
Pediatric Blood & Cancer|October 10, 2019
Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC studyGwénaël Le Teuff, Alicia Castaneda-Heredia, Christelle Dufour, et al.
The New England Journal of Medicine|September 21, 2023
Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 MutationsEric Bouffet, Jordan R Hansford, Maria Luisa Garrè, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2013
Second cranio-facial malignancies in hereditary retinoblastoma survivors previously treated with radiation therapy: clinic and radiologic characteristics and survival outcomesFirazia Rodjan, Pim de Graaf, Hervé J Brisse, et al.
Pediatric Blood & Cancer|November 30, 2016
Feasibility and clinical integration of molecular profiling for target identification in pediatric solid tumorsThomas Pincez, Nathalie Clément, Eve Lapouble, et al.
Pageof 13